728 x 90



  • AstraZeneca Q4 Core Earnings Beat Estimates Despite Esing COVID Vaccine Demand

    AstraZeneca Q4 Core Earnings Beat Estimates Despite Esing COVID Vaccine Demand0

    AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three months ended on December 31 was $1.38, a drop in actual terms of 17% compared

    READ MORE
  • Oil Cools After 3-Day Rally Amid Fed Uncertainty, U.S. inventory Build

    Oil Cools After 3-Day Rally Amid Fed Uncertainty, U.S. inventory Build0

    Oil prices were muted on Thursday as hawkish comments from Federal Reserve officials supported the dollar and brewed some concerns over more interest rate hikes, while U.S. crude inventories also logged a seventh straight week of builds. Hawkish overnight comments from Federal Reserve officials saw markets reassessing their outlook for U.S. interest rate hikes this

    READ MORE
  • Carlsberg Expects Lower Beer Consumption To Hit 2023 Growth

    Carlsberg Expects Lower Beer Consumption To Hit 2023 Growth0

    Danish brewer Carlsberg (OTC:CABGY) on Tuesday forecast organic operating profit growth in 2023 below last year’s level as higher beer prices are expected to dent consumption. The world’s third-biggest brewer expects organic operating profit this year to change by between minus 5% and plus 5%, compared with 12% growth last year. “2023 will be another

    READ MORE